154 related articles for article (PubMed ID: 25456746)
21. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.
Yamaguchi S; Indo Y; Coates PM; Hashimoto T; Tanaka K
Pediatr Res; 1993 Jul; 34(1):111-3. PubMed ID: 8356011
[TBL] [Abstract][Full Text] [Related]
22. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
Leonard JV; Dezateux C
Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
[TBL] [Abstract][Full Text] [Related]
23. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
24. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
Clark-Taylor T; Clark-Taylor BE
Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
[TBL] [Abstract][Full Text] [Related]
25. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
Hall PL; Wittenauer A; Hagar A
Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
[TBL] [Abstract][Full Text] [Related]
26. VLCAD deficiency in a patient who recovered from ventricular fibrillation, but died suddenly of a respiratory syncytial virus infection.
Yamamoto A; Nakamura K; Matsumoto S; Iwai M; Shigematsu Y; Tajima G; Tsumura M; Okada S; Mitsubuchi H; Endo F
Pediatr Int; 2013 Dec; 55(6):775-8. PubMed ID: 24330285
[TBL] [Abstract][Full Text] [Related]
27. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.
Spiekerkoetter U; Lindner M; Santer R; Grotzke M; Baumgartner MR; Boehles H; Das A; Haase C; Hennermann JB; Karall D; de Klerk H; Knerr I; Koch HG; Plecko B; Röschinger W; Schwab KO; Scheible D; Wijburg FA; Zschocke J; Mayatepek E; Wendel U
J Inherit Metab Dis; 2009 Aug; 32(4):488-97. PubMed ID: 19399638
[TBL] [Abstract][Full Text] [Related]
28. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
[TBL] [Abstract][Full Text] [Related]
29. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
[TBL] [Abstract][Full Text] [Related]
30. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
[TBL] [Abstract][Full Text] [Related]
31. [Detection of executive function disorders with a standard neurodevelopmental follow-up of premature children].
Monnier M; Jaunin L; Bickle Graz M; Borradori Tolsa C; Hüppi P; Sancho Rossignol A; Barisnikov K; Forcada Guex M
Arch Pediatr; 2014 Sep; 21(9):944-52. PubMed ID: 25104578
[TBL] [Abstract][Full Text] [Related]
32. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
[TBL] [Abstract][Full Text] [Related]
33. Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency.
Voermans NC; van Engelen BG; Kluijtmans LA; Stikkelbroeck NM; Hermus AR
Am J Med; 2006 Feb; 119(2):176-9. PubMed ID: 16443431
[No Abstract] [Full Text] [Related]
34. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
[TBL] [Abstract][Full Text] [Related]
35. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
[TBL] [Abstract][Full Text] [Related]
36. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
[TBL] [Abstract][Full Text] [Related]
37. Reye syndrome and reye-like syndrome.
Gosalakkal JA; Kamoji V
Pediatr Neurol; 2008 Sep; 39(3):198-200. PubMed ID: 18725066
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
39. Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene.
Antunes AP; Nogueira C; Rocha H; Vilarinho L; Evangelista T
J Clin Neuromuscul Dis; 2013 Dec; 15(2):69-72. PubMed ID: 24263034
[TBL] [Abstract][Full Text] [Related]
40. Outcome in six patients with mitochondrial trifunctional protein disorders identified by newborn screening.
Sperk A; Mueller M; Spiekerkoetter U
Mol Genet Metab; 2010; 101(2-3):205-7. PubMed ID: 20659813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
